Raltegravir in the management of HIV-infected patients

por Stellbrink, Hans-Jürgen
Publicado 2009

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

por Stellbrink, Hans-Jürgen
Publicado 2010

Should we avoid protease inhibitors in first lines due to their lipid side effects? - cons

por Stellbrink, Hans-Jürgen
Publicado 2014

Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review

por Bagnis, Corinne Isnard, Stellbrink, Hans-Jürgen
Publicado 2015

Ongoing epidemic of lymphogranuloma venereum in HIV-positive men who have sex with men: how symptoms should guide treatment

por Mohrmann, Gerrit, Noah, Christian, Sabranski, Michael, Sahly, Hany, Stellbrink, Hans-Jürgen
Publicado 2014

Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure

por Lafeuillade, Alain, Soriano, Vicente, Suzan-Monti, Marie, Stevenson, Mario, Izopet, Jacques, Stellbrink, Hans-Jürgen
Publicado 2012

Mycotic Brain Abscess Caused by Opportunistic Reptile Pathogen

por Steininger, Christoph, van Lunzen, Jan, Tintelnot, Kathrin, Sobottka, Ingo, Rohde, Holger, Horstkotte, Matthias Ansver, Stellbrink, Hans-Jürgen
Publicado 2005

HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance

por Geretti, Anna Maria, Blanco, Jose Luis, Marcelin, Anne Genevieve, Perno, Carlo Federico, Stellbrink, Hans Jurgen, Turner, Dan, Zengin, Tuba
Publicado 2022

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

por Stellbrink, Hans-Jürgen, Reynes, Jacques, Lazzarin, Adriano, Voronin, Eugene, Pulido, Federico, Felizarta, Franco, Almond, Steve, Clair, Marty St, Flack, Nancy, Min, Sherene
Publicado 2013

The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly A...

por Tenner-Racz, Klara, Stellbrink, Hans-Jürgen, van Lunzen, Jan, Schneider, Claus, Jacobs, Jan-Peter, Raschdorff, Birgit, Großschupff, Gudrun, Steinman, Ralph M., Racz, Paul
Publicado 1998

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines

por Treskova, Marina, Kuhlmann, Alexander, Bogner, Johannes, Hower, Martin, Heiken, Hans, Stellbrink, Hans-Jürgen, Mahlich, Jörg, von der Schulenburg, Johann-Matthias Graf, Stoll, Matthias
Publicado 2016

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

por Wolf, Eva, Boesecke, Christoph, Balogh, Annamaria, Bidner, Helen, Cordes, Christiane, Heiken, Hans, Krznaric, Ivanka, Kümmerle, Tim, Stellbrink, Hans-Jürgen, Schneider, Jochen, Spinner, Christoph D.
Publicado 2021

Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression

por Kolbe, Katharina, Wittner, Melanie, Hartjen, Philip, Hüfner, Anja-Dorothee, Degen, Olaf, Ackermann, Christin, Cords, Leon, Stellbrink, Hans-Jürgen, Haag, Friedrich, Schulze zur Wiesch, Julian
Publicado 2022

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany

por Schmidt, Daniel, Kollan, Christian, Fätkenheuer, Gerd, Schülter, Eugen, Stellbrink, Hans-Jürgen, Noah, Christian, Jensen, Björn-Erik Ole, Stoll, Matthias, Bogner, Johannes R., Eberle, Josef, Meixenberger, Karolin, Kücherer, Claudia, Hamouda, Osamah, Bartmeyer, Barbara
Publicado 2014

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort

por Stoll, Matthias, Kollan, Christian, Bergmann, Frank, Bogner, Johannes, Faetkenheuer, Gerd, Fritzsche, Carlos, Hoeper, Kirsten, Horst, Heinz-August, van Lunzen, Jan, Plettenberg, Andreas, Reuter, Stefan, Rockstroh, Jürgen, Stellbrink, Hans-Jürgen, Hamouda, Osamah, Bartmeyer, Barbara
Publicado 2011

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

por Sax, Paul E., Arribas, José R., Orkin, Chloe, Lazzarin, Adriano, Pozniak, Anton, DeJesus, Edwin, Maggiolo, Franco, Stellbrink, Hans-Jürgen, Yazdanpanah, Yazdan, Acosta, Rima, Huang, Hailin, Hindman, Jason T., Martin, Hal, Baeten, Jared M., Wohl, David
Publicado 2023

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

por Stellbrink, Hans-Jürgen, Le Fevre, Eric, Carr, Andrew, Saag, Michael S., Mukwaya, Geoffrey, Nozza, Silvia, Valluri, Srinivas Rao, Vourvahis, Manoli, Rinehart, Alex R., McFadyen, Lynn, Fichtenbaum, Carl, Clark, Andrew, Craig, Charles, Fang, Annie F., Heera, Jayvant
Publicado 2016

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

por Berkowitz, Elchonon M., Moyle, Graeme, Stellbrink, Hans-Jürgen, Schürmann, Dirk, Kegg, Stephen, Stoll, Matthias, El Idrissi, Mohamed, Oostvogels, Lidia, Heineman, Thomas C., Brockmeyer, Norbert, deJesus, Edwin, Esser, Stefan, Hawkins, Trevor, Lalezari, Jacob, Orkin, Chloe, Schneider, Stefan
Publicado 2015

Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study

por Maasoumy, Benjamin, Ingiliz, Patrick, Spinner, Christoph D., Cordes, Christiane, Stellbrink, Hans-Jürgen, Schulze zur Wiesch, Julian, Schneeweiß, Stephan M., Deterding, Katja, Müller, Tobias, Kahlhöfer, Julia, Dörge, Petra, von Karpowitz, Maria, Manns, Michael P., Wedemeyer, Heiner, Cornberg, Markus
Publicado 2022

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

por Gatell, José M., Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans–Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Pozniak, Anton L.
Publicado 2017